ANIP
ANI Pharmaceuticals Inc
NASDAQ: ANIP · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$71.71
+0.76% today
Updated 2026-10-28
Market cap
$1.66B
P/E ratio
15.65
P/S ratio
1.70x
EPS (TTM)
$4.62
Dividend yield
—
52W range
$70 – $97
Volume
0.4M
ANI Pharmaceuticals Inc (ANIP) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$71.71
12-Month target
$61.55
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.5B | $0.6B | $0.9B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 15.65x (capped 25x) · Margin: 11.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.